Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MRI Labeling For Boston Scientific's Emblem MRI S-ICD Approved By US FDA

Executive Summary

Boston Scientific cardiac rhythm management has been struggling to compete with MRI-compatible devices from rival Medtronic.


Related Content

Device Debuts: BSX's Resonate ICD; SYK's Tritanium C Anterior Cervical Cage; ZBH's Persona Partial Knee; MDT's Concerto 3D Coil
HRS 2017: Medtronic And Boston Scientific's Less-Invasive CRM Devices Perform As Hoped In Real-World Registries
Abbott Finally Joins MRI-Compatibility Club In US CRM Market
Earnings Winners And Losers: BSX, BCR, NUVA, NVCR
HRS 2016 ROUND-UP: Medtronic Unveils New “Extravascular ICD”
APPROVALS ANALYSIS: Big Month For Cardio Devices, But Down Overall
Earnings Winners And Losers: BSX, CYNO, EW, GB, STJ, BCR, EXAC
APPROVALS ANALYSIS: MR-Compatible CRM Devices Lead Big Cardiovascular Crop
Boston Scientific gets early nod for next-gen S-ICD


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts